Have a personal or library account? Click to login
Genetic polymorphism of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) in patients with bullous pemphigoid in a Polish population Cover

Genetic polymorphism of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) in patients with bullous pemphigoid in a Polish population

Open Access
|Dec 2021

Figures & Tables

Demographic and clinical characteristics of study participants

Sex n (%)Age (mean ± SD)BDAI (mean ± SD)VAS (itching)Anti-BMZ antibodies
Patients with BP n=71F: 47 (66.2)M: 24 (33.8)66.3 ± 15.039 ± 164 - 10 (median 8)1:80 to 1:320 (median 1:160)
Controls n=100F: 45 (45)M: 55 (55)36.9 ± 12.5---

Association of GSTM1 and GSTT1 polymorphisms with the risk of BP

PolymorphismBP n=71 n (%)Controls n=100 n (%)p-valueOR (95% CI)
GSTM1 non-null29 (40.8)48 (48)0.35410.75 (0.40-1.38)
GSTM1 null42 (59.2)52 (52)0.35411.34 (0.72-2.47)
GSTT1 non-null51 (71.8)76 (76)0.53890.81 (0.40-1.61)
GSTT1 null20 (28.2)24 (24)0.53891.24 (0.62-2.48)
Double polymorphisms
GSTM1/GSTT1 non-null/non-null20 (28.2)37 (37)0.22740.67 (0.35-1.29)
GSTM1/GSTT1 null/non-null31 (43.6)39 (39)0.54121.21 (0.65-2.25)
GSTM1/GSTT1 non-null/null9 (12.7)11 (11)0.73681.17 (0.46-3.00)
GSTM1/GSTT1 null/null11 (15.5)13 (13)0.64371.23 (0.52-2.92)

The distribution of particular genotypes and alleles for the Ile105Val GSTP1 polymorphism in the group of BP patients and in the control group

Ile105Val GSTP1 polymorphismBP n=71 n (%)Controls n=100 n (%)p-valueOR (95%CI)
Genotype
Ile/Ile (wild type)46 (64.8)65 (65)0.97720.99 (0.52-1.87)
Ile/Val20 (28.2)31 (31)0.69010.87 (0.45-1.70)
Val/Val5 (7.0)4 (4)0.59581.82 (0.47-7.03)
GSTP1
Ile/Ile (wild type)46 (64.8)65 (65)0.97720.99 (0.52-1.87)
Ile/Val and Val/Val25 (35.2)35 (35)0.97721.01 (0.53-1.91)
Allele
Ile112 (78.9)161 (80.5)0.71180.90 (0.53-1.54)
Val30 (21.1)39 (19.5)0.71181.11 (0.65-1.89)

The combined effect of GST polymorphisms on the risk of BP

GSTs polymorphismsBP n=71 n (%)Control n=100 n (%)p-valueOR (95% CI)
GSTM1GSTT1GSTP1
Non-nullNon-nullIle/Ile14 (19.7)23 (23.0)0.60760.82 (0.39- 1.74)
Non-nullNullIle/Ile6 (8.5)10 (10.0)0.73180.83 (0.29- 2.40)
NullNon-nullIle/Ile21 (29.6)23 (23.0)0.33231.41 (0.70- 2.80)
NullNullIle/Ile5 (7.0)9 (9.0)0.85940.77 (0.25- 2.39)
Non-nullNullIle/Val, Val/Val3 (4.2)1 (1.0)0.38894.37 (0.44-42.88)
NullNon-nullIle/Val, Val/Val11 (15.5)16 (16.0)0.92860.96 (0.42- 2,22)
NullNullIle/Val, Val/Val6 (8.5)4 (4.0)0.37272.22 (0.60- 8.16)
Non-nullNon-nullIle/Val, Val/Val5 (7.0)14 (14.0)0.23810.47 (0.16- 1.36)
Language: English
Page range: 896 - 903
Submitted on: Sep 2, 2020
|
Accepted on: May 25, 2021
|
Published on: Dec 30, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Mariola Rychlik-Sych, Małgorzata Barańska, Michał Dudarewicz, Jadwiga Skrętkowicz, Agnieszka Żebrowska, Jacek Owczarek, Anna Wiktorowska-Owczarek, Daria Orszulak-Michalak, Elżbieta Waszczykowska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.